InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Nader Francois, Director. Officer active across 5 companies, notably ALEXION PHARMACEUTICALS, INC.. In total, 10 disclosures have been recorded. The latest transaction was filed on 10 May 2022 — Levée d'options. Regulator: SEC (Form 4). All data is free.
Declarations10 total
€413,84123,100 shares@ €17.91520.0036% mcap100.0% of flow
Common Stock
SEC:0001127602-22-014263:0·
0703 shares0
Common Stock
SEC:0001127602-22-012857:0·
059,520 shares0
Common Stock
SEC:0000899243-21-048599·
059,520 shares0
Common Stock
SEC:0000899243-21-048599:0·
6,749 shares
Common Stock
SEC:0001104659-21-142272·
6,749 shares
Common Stock
SEC:0001104659-21-142272:0·
013,921 shares0
Common Stock, par value $.0001 per share
SEC:0000899866-21-000065·
013,921 shares0
Common Stock, par value $.0001 per share
SEC:0000899866-21-000065:0·
01,962 shares0
Common Stock, par value $.0001 per share
SEC:0000899866-21-000043·
01,962 shares0
Common Stock, par value $.0001 per share
SEC:0000899866-21-000043:0·
10 of 10 declarations
About Nader Francois
Francois Nader is a Board Member of ALEXION PHARMACEUTICALS, INC., ACCELERON PHARMA INC, and Talaris Therapeutics, Inc. He plays a key role in the governance of these companies and brings his expertise in strategy and business development.
